Lek to move antibiotics production from Slovenia to Austria
Prevalje, 1 October - Lek, the Slovenian subsidiary of Swiss multinational Novartis, has announced phasing out the production of antibiotics in Slovenia's Prevalje in two years' time and moving it to neighbouring Austria. In the meantime, Prevalje will become one of the two locations of Novartis's emerging global centre for technical operations.
Prevelje
Lek's production facility in the town of Prevalje, which employs 320 workers.
Photo: Vesna Pušnik Brezovnik/STA
Prevelje
Prevalje Mayor Matic Tasič.
Photo: Vesna Pušnik Brezovnik/STA
Prevelje
Raul Intriago Lombeida, a new Lek board member in charge of Novartis's technical operations, Antiinfektivi Prevalje director Roman Burja, and Lek director general and Novartis's president in Slovenia Robert Ljoljo.
Photo: Vesna Pušnik Brezovnik/STA
Prevelje
Raul Intriago Lombeida, a new Lek board member in charge of Novartis's technical operations, Antiinfektivi Prevalje director Roman Burja, and Lek director general and Novartis's president in Slovenia Robert Ljoljo.
Photo: Vesna Pušnik Brezovnik/STA
Prevelje
Lek's production facility in the town of Prevalje, which employs 320 workers.
Photo: Vesna Pušnik Brezovnik/STA
The rest of this news item is available to subscribers.
The news item consists of 1.743 characters (without spaces) or 329 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.